Nyxoah SA (NYXH): Price and Financial Metrics


Nyxoah SA (NYXH): $7.47

0.16 (+2.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NYXH Stock Price Chart Interactive Chart >

Price chart for NYXH

NYXH Price/Volume Stats

Current price $7.47 52-week high $19.31
Prev. close $7.31 52-week low $4.36
Day low $7.10 Volume 3,200
Day high $7.82 Avg. volume 32,695
50-day MA $5.63 Dividend yield N/A
200-day MA $7.18 Market Cap 186.32M

Nyxoah SA (NYXH) Company Bio


Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.


NYXH Latest News Stream


Event/Time News Detail
Loading, please wait...

NYXH Latest Social Stream


Loading social stream, please wait...

View Full NYXH Social Stream

Latest NYXH News From Around the Web

Below are the latest news stories about NYXOAH SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.

Nyxoah Raises $3 Million from an At-the-Market Equity Offering

INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Raises $3 Million from an At-the-Market Equity Offering Mont-Saint-Guibert, Belgium – March 27, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $2.8 million in gross proceeds pursuant to the Company’s $50 million at

Yahoo | March 27, 2023

Nyxoah S.A. (NASDAQ:NYXH) Q4 2022 Earnings Call Transcript

Nyxoah S.A. (NASDAQ:NYXH) Q4 2022 Earnings Call Transcript March 22, 2023 Operator: Thank you for standing by. And welcome to the Nyxoah Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. As a reminder, today’s call is being […]

Yahoo | March 27, 2023

Nyxoah Announces a $15 Million Private Placement Financing

INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces a $15 Million Private Placement Financing Mont-Saint-Guibert, Belgium – March 23, 2023, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced a €13.35 million private placement financing from the sale of 2,047,544 new ordinary shares at a pri

Yahoo | March 23, 2023

Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating ResultsCompleted all 115 implants in the DREAM U.S. pivotal study Mont-Saint-Guibert, Belgium – March 22, 2023 09:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the

Yahoo | March 22, 2023

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the fourth quarter and full year 2022 on Wednesday, March 2

Yahoo | March 8, 2023

Read More 'NYXH' Stories Here

NYXH Price Returns

1-mo 38.33%
3-mo 49.70%
6-mo 18.57%
1-year -60.97%
3-year N/A
5-year N/A
YTD 49.70%
2022 -78.30%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7198 seconds.